CHM 10.5% 2.1¢ chimeric therapeutics limited

Ann: First patient enrolled in CHM CDH17 Phase 1/2 clinical trial, page-7

  1. 34 Posts.
    lightbulb Created with Sketch. 25
    Another major derailing event for CHM. Lead therapy is now in the clinic….

    only a single dose of CDH17 CART is contemplated for each patient for the trial. If we see early efficacy signals and low toxicity during the dose escalation then LOOKOUT!
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
0.002(10.5%)
Mkt cap ! $19.27M
Open High Low Value Volume
1.9¢ 2.2¢ 1.9¢ $53.04K 2.550M

Buyers (Bids)

No. Vol. Price($)
3 240967 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 922473 1
View Market Depth
Last trade - 15.54pm 22/07/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.